Solid Tumor Second Primary Neoplasms: Who Is at Risk, What Can We Do?

被引:57
作者
Oeffinger, Kevin C. [1 ,2 ]
Baxi, Shrujal S. [1 ]
Friedman, Danielle Novetsky [2 ]
Moskowitz, Chaya S. [3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10065 USA
关键词
BREAST-CANCER RISK; LONG-TERM SURVIVORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; SQUAMOUS-CELL CARCINOMA; CORONARY-HEART-DISEASE; CHILDHOOD HODGKINS-DISEASE; PRIMARY THYROID-CANCER; FOLLOW-UP; ADULT SURVIVORS; MALIGNANT NEOPLASMS;
D O I
10.1053/j.seminoncol.2013.09.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Eighteen percent of incident malignancies in the United States are a second (or subsequent) cancer. Second primary neoplasms (SPNs), particularly solid tumors, are a major cause of mortality and serious morbidity among cancer survivors successfully cured of their first cancer. Multiple etiologies may lead to a cancer survivor subsequently being diagnosed with an SPN, including radiotherapy for the first cancer, unhealthy lifestyle behaviors, genetic factors, aging, or an interaction between any of these factors. In this article, we discuss these factors and synthesize this information for use in clinical practice, including preventive strategies and screening recommendations for SPNs. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:676 / 689
页数:14
相关论文
共 124 条
[1]   Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].
Aberle, Denise R. ;
Adams, Amanda M. ;
Berg, Christine D. ;
Black, William C. ;
Clapp, Jonathan D. ;
Fagerstrom, Richard M. ;
Gareen, Ilana F. ;
Gatsonis, Constantine ;
Marcus, Pamela M. ;
Sicks, JoRean D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409
[2]   Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma [J].
Abramson, DH ;
Melson, MR ;
Dunkel, IJ ;
Frank, CM .
OPHTHALMOLOGY, 2001, 108 (10) :1868-1876
[3]   Factors Affecting Long-Term Survival in Patients with Recurrent Head and Neck Cancer May Help Define the Role of Post-Treatment Surveillance [J].
Agrawal, Amit ;
Hammond, Thomas H. ;
Young, Gregory S. ;
Avon, Amanda L. ;
Ozer, Enver ;
Schuller, David E. .
LARYNGOSCOPE, 2009, 119 (11) :2135-2140
[4]  
[Anonymous], CANC PRINCIPLES PRAC
[5]  
[Anonymous], 2008, Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers
[6]   Benefits and Harms of CT Screening for Lung Cancer A Systematic Review [J].
Bach, Peter B. ;
Mirkin, Joshua N. ;
Oliver, Thomas K. ;
Azzoli, Christopher G. ;
Berry, Donald A. ;
Brawley, Otis W. ;
Byers, Tim ;
Colditz, Graham A. ;
Gould, Michael K. ;
Jett, James R. ;
Sabichi, Anita L. ;
Smith-Bindman, Rebecca ;
Wood, Douglas E. ;
Qaseem, Amir ;
Detterbeck, Frank C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22) :2418-2429
[7]   Increased risk of rectal cancer after prostate radiation: A population-based study [J].
Baxter, NN ;
Tepper, JE ;
Durham, SB ;
Rothenberger, DA ;
Virnig, BA .
GASTROENTEROLOGY, 2005, 128 (04) :819-824
[8]   Variation of breast cancer risk among BRCA1/2 carriers [J].
Begg, Colin B. ;
Haile, Robert W. ;
Borg, Ake ;
Malone, Kathleen E. ;
Concannon, Patrick ;
Thomas, Duncan C. ;
Langholz, Bryan ;
Bernstein, Leslie ;
Olsen, Jorgen H. ;
Lynch, Charles F. ;
Anton-Culver, Hoda ;
Capanu, Marinela ;
Liang, Xiaolin ;
Hummer, Amanda J. ;
Sima, Cami ;
Bernstein, Jonine L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (02) :194-201
[9]   Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma [J].
Best, Timothy ;
Li, Dalin ;
Skol, Andrew D. ;
Kirchhoff, Tomas ;
Jackson, Sarah A. ;
Yasui, Yutaka ;
Bhatia, Smita ;
Strong, Louise C. ;
Domchek, Susan M. ;
Nathanson, Katherine L. ;
Olopade, Olufunmilayo I. ;
Huang, R. Stephanie ;
Mack, Thomas M. ;
Conti, David V. ;
Offit, Kenneth ;
Cozen, Wendy ;
Robison, Leslie L. ;
Onel, Kenan .
NATURE MEDICINE, 2011, 17 (08) :941-943
[10]   High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group [J].
Bhatia, S ;
Yasui, Y ;
Robison, LL ;
Birch, JM ;
Bogue, MK ;
Diller, L ;
DeLaat, C ;
Fossati-Bellani, F ;
Morgan, E ;
Oberlin, O ;
Reaman, G ;
Ruymann, FB ;
Tersak, J ;
Meadows, AT .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) :4386-4394